| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;42:136.)
© 2003 American Heart Association, Inc.
Scientific Contributions |
From the Clinical Neurocardiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md.
Correspondence to Dr David S. Goldstein, NINDS, NIH, Bldg 10, Room 6N252, 10 Center Dr, MSC-1620, Bethesda, MD 20892-1620. E-mail goldsteind{at}ninds.nih.gov
Supine hypertension occurs commonly in primary chronic autonomic failure. This study explored whether supine hypertension in this setting is associated with orthostatic hypotension (OH), and if so, what mechanisms might underlie this association. Supine and upright blood pressures, hemodynamic responses to the Valsalva maneuver, baroreflex-cardiovagal gain, and plasma norepinephrine (NE) levels were measured in pure autonomic failure (PAF), multiple-system atrophy (MSA) with or without OH, and Parkinsons disease (PD) with or without OH. Controls included age-matched, healthy volunteers and patients with essential hypertension or those referred for dysautonomia. Baroreflex-cardiovagal gain was calculated from the relation between the interbeat interval and systolic pressure during the Valsalva maneuver. PAF, MSA with OH, and PD with OH all featured supine hypertension, which was equivalent in severity to that in essential hypertension, regardless of fludrocortisone treatment. Among patients with PD or MSA, those with OH had higher mean arterial pressure during supine rest (109±3 mm Hg) than did those lacking OH (96±3 mm Hg, P=0.002). Baroreflex-cardiovagal gain and orthostatic increments in plasma NE levels were markedly decreased in all 3 groups with OH. Among patients with PD or MSA, those with OH had much lower mean baroreflex-cardiovagal gain (0.74±0.10 ms/mm Hg) than did those lacking OH (3.13±0.72 ms/mm Hg, P=0.0002). In PAF, supine hypertension is linked to both OH and low baroreflex-cardiovagal gain. The finding of lower plasma NE levels in patients with than without supine hypertension suggests involvement of pressor mechanisms independent of the sympathetic nervous system.
Key Words: hypertension, essential hypotension Parkinsons disease autonomic nervous system sympathetic nervous system norepinephrine
This article has been cited by other articles:
![]() |
D. S. Goldstein, C. Holmes, L. Sewell, and I. J. Kopin Hypertension Increases Cerebral 6-18F-Fluorodopa-Derived Radioactivity J. Nucl. Med., September 1, 2009; 50(9): 1479 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Goldstein and Y. Sharabi Neurogenic Orthostatic Hypotension: A Pathophysiological Approach Circulation, January 6, 2009; 119(1): 139 - 146. [Full Text] [PDF] |
||||
![]() |
V. Adhiyaman, P. Hobson, and R. J. Meara Central and peripheral autonomic integrity in Parkinson's disease Age Ageing, September 1, 2008; 37(5): 578 - 581. [Full Text] [PDF] |
||||
![]() |
D Gupta and M D Nair Neurogenic orthostatic hypotension: chasing "the fall" Postgrad. Med. J., January 1, 2008; 84(987): 6 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Oka, M. Yoshioka, K. Onouchi, M. Morita, S. Mochio, M. Suzuki, T. Hirai, Y. Ito, and K. Inoue Characteristics of orthostatic hypotension in Parkinson's disease Brain, August 2, 2007; (2007) awm174v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Barbic, F. Perego, M. Canesi, M. Gianni, S. Biagiotti, G. Costantino, G. Pezzoli, A. Porta, A. Malliani, and R. Furlan Early Abnormalities of Vascular and Cardiac Autonomic Control in Parkinson's Disease Without Orthostatic Hypotension Hypertension, January 1, 2007; 49(1): 120 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E Naschitz, G Slobodin, N Elias, and I Rosner The patient with supine hypertension and orthostatic hypotension: a clinical dilemma. Postgrad. Med. J., April 1, 2006; 82(966): 246 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Goldstein, B. A. Eldadah, C. Holmes, S. Pechnik, J. Moak, A. Saleem, and Y. Sharabi Neurocirculatory Abnormalities in Parkinson Disease With Orthostatic Hypotension: Independence From Levodopa Treatment Hypertension, December 1, 2005; 46(6): 1333 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Tipre and D. S. Goldstein Cardiac and Extracardiac Sympathetic Denervation in Parkinson's Disease with Orthostatic Hypotension and in Pure Autonomic Failure J. Nucl. Med., November 1, 2005; 46(11): 1775 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Schatz, D. S. Goldstein, R. A. Martin, M. G. Schlossmacher, and C. Hamann Case 27-2004: Multiple-System Atrophy N. Engl. J. Med., December 30, 2004; 351(27): 2881 - 2883. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |